HIV-specific CD8 T cells play a crucial role in controlling HIV replication. Although they have efficient effector function, CD8 T cells fail to clear HIV infection even in the presence of ART. Here we describe how ART can impact CD8 T cell effector function and therefore interfere -among other factors- with clearance of HIV infected cells.
PBMCs from HIV+ (n=44) and healthy (n=32) individuals were analyzed via flow cytometry to determine phenotype and functional properties of HIV-specific CD8 T cells in the presence of ART drugs and performed ex vivo proliferation assays of PBMCs from treated HIV+ individuals. We used a viral inhibition assay to determine CD8 T cells clear HIV infected cells and analyzed metabolic profiles using extracellular flux analyzer.
We assessed CD8 T cell functions in HIV+ ART-treated individuals ex vivo and observed a reduction in cellular function compared to CD8 T cells of HIV+ treatment naïve individuals (p<0.01). We next assessed the proliferation index ex vivo and found a reduction in CD8 T cells of individuals treated with INSTI-based ART regimen (2.43±0.36) compared to both PI (2.79±0.35;p<0.05) and NNRTI (2.92±0.28;p<0.01) based regimens. As we saw a significant impact of INSTI-based regimens on CD8 T cell function, we cultured CD8 T cells with individual ART drugs and determined the impact on CD8 T cell function of each drug individually. CD8 T cells had reduced functional properties with significantly lower expression of IFNγ (p<0.01), IL-2 (p<0.01) as well as TNFα (p<0.01) after treatment with INSTI, but not with other ART drugs. Due to the observed decrease in cytokine expression we decided to examine the killing ability of HIV-specific CD8 T cells in presence of individual ART regimens. Previously INSTI-treated CD8 T cells demonstrated reduced viral inhibitory activity against HIV-infected CD4 T cells compared to PI or NNRTI treated cells. We used a live cell imaging assay to determine the migratory capacity of CD8 T cells treated with different ART regimens. DLG-treated cells showed less migration activity after SDF1α stimulation compared to NRTI regimens (p=0.07). Next, we investigated the respiration of CD8 T cells treated with individual ART regimens and observed a significant reduction (p<0.05) in INSTI-treated cells compared to NRTI-treated cells.
Our data shows that the choice of ART can have a significant impact on CD8 T cell effector function. This may have important implications for HIV eradication strategies.